Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Patient Information Urology Centre ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT Frequently-Asked Questions What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication of prostate cancer, is available to you if you want to be tested. However, experts disagree on how useful the PSA test is. This is why there is a lot of research and why there is no national screening programme for prostate cancer in the UK. The aim of this leaflet is to give you a balanced view about the PSA test and to raise matters which you may wish to think about. We hope it will help you decide whether or not you should have the test but there is, of course, no simple right or wrong answer. You may want to talk about this information with your doctor or a trained practice nurse and, in addition, you may wish to speak to your partner about it. What is the prostate? The prostate is a sex gland which lies just below the bladder in men. It provides fluid to help produce healthy sperm. The prostate surrounds the tube (called the urethra) that carries urine out through the penis. Because of this, problems affecting the prostate gland can sometimes affect how you urinate as we as possible changing your sexual function. Prostate cancer is the commonest cancer and the second most common cause of cancer death in men in the UK. Each year in the UK, about 35,000 men are diagnosed with prostate cancer and 10,000 die from the disease. Prostate cancer is less common in men below the age of 50 years and the average age for diagnosis is 70 to 74 years. The risk is greater form men who have a family history of prostate cancer and in black-African or black-Caribbean men. Prostate cancer is also more common in developed, western countries, suggesting that there may be a link with lifestyle factors such as diet. Prostate cancer can grow very slowly or very quickly. Slow-growing cancers are common and may not cause symptoms or shorten life. Prostate cancer is the second most common cause of cancer deaths in the UK. Each year, about 35,000 men are diagnosed with prostate cancer and 10,000 die for the disease. Prostate cancer is less common in men under the age of 50 years. What is a PSA test? The PSA test is a blood test that measures the level of prostate specific antigen (PSA) in your blood. PSA is made by the prostate gland and some of it will leak into your bloodstream, depending on your age and the health of your prostate. Patient Information Although the PSA test is often done to detect cancer in men who have problems passing urine and is also used to help in the treatment of men who are known to have prostate cancer, it can also detect early prostate cancer before it causes symptoms or any abnormality of the prostate. Although using the PSA test in this way to screen for prostate cancer is sometimes recommended, some doctors do not think it is necessarily a good thing because it may detect very small cancers that pose no risk to your health. A raised level may mean you have prostate cancer. About 2 out of 3 men with a raised PSA level will not have prostate cancer. The higher the levels of PSA, the more likely it is to be a sign of cancer. The PSA test can also miss cancer. However, other conditions which are not cancerous (for example, benign enlargement of the prostate, prostatitis, and urinary infection) can also cause higher PSA levels in the blood. When you have a PSA test, you should not have: an active urinary infection ejaculated within the last 48 hours exercised heavily within the last 48 hours had a prostate biopsy within the last 6 weeks had a digital rectal examination (DRE) within the last week What happens if the PSA is high? There are usually three main options after a PSA test: If your PSA level is not raised, you are unlikely to have prostate cancer and no immediate further action is needed, although you may have follow-up PSA tests to confirm the result If your PSA level is slightly raised, you probably do not have cancer but you may need further tests, including follow-up PSA tests If your PSA is definitely raised, your GP will arrange for you to see a specialist for further tests to find out if you have prostate cancer If your PSA is shown to be high, your GP will normally refer you to an urologist. The urologist will discuss whether further investigations should be done. A biopsy may be advised to see if cancer is present. This is done with a transrectal ultrasound scanner, a metal probe passed into the rectum (back passage) with the help of local anaesthetic. This test is a little uncomfortable and can be painful, but does not normally need a general anaesthetic. Antibiotics are given to reduce the risk of infection Complications can follow this test - bleeding can occur or infection in the urine, the prostate or the blood. Patient Information Even if the biopsy test is negative, this does not necessarily completely rule out prostate cancer. Usually, it will be necessary to have the PSA test repeated, and sometimes further biopsies are needed. It is important to realise that, if your PSA is raised, even if you do not have cancer, it can be very difficult to rule out cancer and you may need to go on having tests for some time. If the tests show cancer, how is it treated? The following points are important for you to understand: If the biopsy does show cancer, you and your urologist will have to make a decision about how to treat it. This might involve an operation to remove the whole prostate gland (radical prostatectomy) or radiotherapy. Sometimes, it might be best simply to do nothing immediately (active surveillance, active monitoring or watchful waiting) ; this usually involves using PSA tests and clinical examination of the prostate to see if the cancer is growing. A disadvantage is that the cancer may grow to a more advanced stage and PSA tests or biopsies may need to be repeated. You may find it difficult to cope with this uncertainty. Surgery involves an operation to remove the prostate gland. The aim is to cure the cancer but there are possible side-effects. Up to 3 in every 20 men may experience some bladder problems and 8 out of 10 men experience difficulty in obtaining or maintaining an erection. Some men may be able to orgasm but will not be able to ejaculate so that fertility is affected Radiotherapy involves a course of radiation treatment on the prostate gland (external beam) or with radioactive implants (brachytherapy). The aim is to cure the cancer but there are possible side-effects. After external beam radiotherapy, half of those treated may have problems obtaining or maintaining an erection and may not be able to ejaculate. Up to 3 in 10 men have diarrhoea & bowel problems whilst 1 in every 25 has bladder problems. After brachytherapy, you may have problems obtaining or maintaining an erection and you may not be able to ejaculate. Up to 1 in 15 men has bladder problems. The best way of treating early prostate cancer is not clear. Treating some cancers at an early stage should prevent more serious cancer developing in Patient Information the future, but the side-effects of treatment may outweigh any benefits. It is difficult to be precise about predicting what is right for each individual person At present there is no definite proof that using PSA tests to diagnose early cancer does save lives. Some doctors believe that it does and some that it does not. We should, however, have further information about this from clinical trials within the next 2-3 years. What if there is a family history of cancer? You may be asking for a test because a relative has had prostate cancer. Prostate cancer can run in families, but it is only if it is a close relative (e.g. father or brother), or, especially, two or more close relatives, that the increased risk is important. This is particularly so if they have developed the disease at a young age Although the chance of your having prostate cancer might be higher in these circumstances, it is still fairly small (10-15%) The higher the PSA value, the more likely cancer will be found. If your PSA is greater than 10 µg/l, the risk of finding prostate cancer is 50% Even if you have a family history of prostate cancer, all the information given above still applies to you and must be considered. There is no real evidence that men who are relatives of patients with prostate cancer benefit from being screened. Should I have the PSA test? The benefits of PSA testing It may reassure you if the test result is normal It may give you an indication of cancer before symptoms develop It may find cancer at an early stage when treatments could be of benefit If treatment is successful, the worst possible outcomes of more advanced cancer, including death, are avoided Even if the cancer is more advanced and treatment is less successful, it will usually extend life. The limitations of PSA testing It can miss cancer and provide false reassurance It may lead to unnecessary worry and medical tests when there is no cancer Patient Information It cannot tell the difference between slow-growing and fast-growing cancer It may make you worry by finding slow-growing cancers that may never causes symptoms or shorten your life 48 men will undergo treatment in order to save one life. This publication provides input from specialists, the Cancer Research UK Primary Care Education Research Group, the University of Oxford & Professor Michael Kirby, visiting Professor to the Faculty of Health & Human Sciences at the University of Hertfordshire. The following websites may help you decide whether the PSA tests is right for you: http://www.prosdex.com http://cancerscreening.nhs.uk/prostate/index.html PSA MEASUREMENTS Frequently-Asked Questions What are the maximum PSA levels? Age (yr) 40-29 50-49 60-69 70-75 Max PSA 2.7 3.9 5.0 7.2 These are age-related maximum levels but it is now clear that there is no real “safe” maximum level (see below). Is the test useful in people with a short life-expectancy? There is some doubt about the clinical usefulness of routine PSA measurements in patients with a life expectancy less than 5-10 years. In such patients, particularly if they have several other serious illnesses, it has been suggested that PSA should only be measured if the prostate is suspicious of malignancy on digital rectal examination (DRE) or if the patient has severe lower urinary tract symptoms, haematuria or bone pain What is the sensitivity of the test? The sensitivity and specificity of PSA in discriminating between cancer and BPH is somewhat limited. Even in men with a high PSA, only 30% are found to have a prostate cancer on biopsy; in men with a PSA <2.5, about 15% are found to have prostate cancer on biopsy. Patient Information The sensitivity can be improved by measuring both the free and the bound fractions of PSA and calculating the free/total PSA ratio (FTR). This service is now available for all PSA measurements. What about the free-total PSA ratio? Between the age-specific maxima (see table above) and 17, the FTR is a slightly better discriminator than total PSA alone. A low FTR (<17%) tends to suggest carcinoma and a high FTR (>22%) suggests BPH. If the total PSA is >17 or if the patient has known prostate cancer, the FTR will not have any useful role. If the PSA is normal, the FTR is not used as an indicator for biopsy. The main role for FTR is to try and avoid biopsy in an elderly man who has a large benign feeling prostate. If the FTR is >22% then biopsy can be avoided. How does all this help urologists and patients? FTR assays do enable the urology team to make better decisions about the need for prostate biopsy so you are asked to report the FTR as well as the total PSA in your referral letters. The use of FTR may help to reduce delay in referral of men whose total PSA is only marginally raised, but whose FTR is low. Patient Information Are there any other important points? This publication provides input from specialists, the British Association of Urological Surgeons, the Department of Health and evidence-based sources as a supplement to any advice you may already have been given by your GP. Alternative treatments can be discussed in more detail with your urologist or Specialist Nurse. Disclaimer While every effort has been made to ensure the accuracy of the information contained in this publication, no guarantee can be given that all errors and omissions have been excluded. No responsibility for loss occasioned by any person acting or refraining from action as a result of the material in this publication can be accepted by the British Association of Urological Surgeons Limited. Mid Essex Hospital services NHS Trust is smoke-free. You cannot smoke on site. For advice on quitting, contact your GP or the NHS smoking helpline free, 0800 169 0 169 Please ask if you require this information in other languages, large print or audio format: (01245) 514235 Broomfield Urology Centre Location zone B446 These leaflets are funded from charitable funds. Registered Charity No 1048542 Making a donation Sometimes patients, family members or friends wish to make a donation to say thank you for care and treatment received. We will always let you know how your donation has been used and how patients are benefiting from your support. If you would like to make a donation to the Broomfield Urology Centre Fund, please contact the charities office direct on 01245 514559 Document history Authors Department Contact number Published Review date Supersedes which document? File name Version number Ref British Association of Urological Surgeons Urology 01245 513818 May 2011 May 2014 N/A ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT 1.0 MEHT000067